Macrocure is currently conducting a phase III clinical trial for the treatment of Lower Extremity Chronic Ulcers in Adults With Diabetes. CureXcell is an injected formulation of activated leukocytes. Clinical sites in the US, Canada and Israel are actively recruiting participants in this study.
Please follow the link for more information and a list of clinical study sites: